Most Recent Articles by Tara Haelle, MS
The reasons for physicians' discomfort with conversations about dying are as much cultural, social, and systemic as they are personal.
The potential consequences of providing cosmetic treatment to a patient with BDD can extend beyond ethical concerns.
FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?Jul 23, 2018
Abilify MyCite adds a digital sensor to the medication aripiprazole. The sensor, an ingestible event marker, is activated by contact with stomach acids and transmits a signal to a skin patch the patient wears, which then transmits to an app.
While researchers continue learning about specific interactions between poor sleep and psychotic symptoms, clinicians should be incorporating more comprehensive questions about sleep into their assessment of patients.
Parents using intervention strategies in addition to the interventionist working directly with the child can be very beneficial, as an interventionist only gets to see a child for a few hours a week.
More Articles by Tara Haelle, MS
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- Minocycline vs Routine Care for Clinical Symptom Improvement in Schizophrenia
- Insomnia in Borderline Personality Disorder May Increase Suicide Risk
- Mortality Rates in Parkinson Disease Psychosis With Pimavanserin, Quetiapine
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Psychotropic Medication May Reduce Symptoms and Improve Functioning in PTSD
- Social Decline a Predictor of Conversion Outcome in High-Risk Individuals
- Buprenorphine/Samidorphan Helpful in Refractory Depression
- Depression and Alcohol Misuse Lower Odds of Achieving Viral Suppression in HIV